MAPT and Alzheimer disease: While the severity of tau pathology in the LC increases with increasing NFT stages, there are still cases with considerable entorhinal tau pathology and only minimal amounts of tau pathology seen in the LC: It has, thus, been argued [102] that the LC becomes increasingly involved during AD progression rather than being the site initially affected.